LFA-1 on CD4+ T Cells Is Required for Optimal Antigen-Dependent Activation In Vivo
Authors:
Open Access
- 1 October 2004
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 173 (7) , 4443-4451
Abstract
The leukocyte-specific integrin, LFA-1, plays a critical role in trafficking of T cells to both lymphoid and nonlymphoid tissues. However, the role of LFA-1 in T cell activation in vivo has been less well understood. Although there have been reports describing LFA-1-deficient T cell response defects in vivo, due to impaired migration to lymphoid structures and to sites of effector function in the absence of LFA-1, it has been difficult to assess whether T cells also have a specific activation defect in vivo. We examined the role of LFA-1 in CD4+ T cell activation in vivo by using a system that allows for segregation of the migration and activation defects through the adoptive transfer of LFA-1-deficient (CD18−/−) CD4+ T cells from DO11.10 Ag-specific TCR transgenic mice into wild-type BALB/c mice. We find that in addition to its role in trafficking to peripheral lymph nodes, LFA-1 is required for optimal CD4+ T cell priming in vivo upon s.c. immunization. CD18−/− DO11.10 CD4+ T cells primed in the lymph nodes demonstrate defects in IL-2 and IFN-γ production. In addition, recipient mice adoptively transferred with CD18−/− DO11.10 CD4+ T cells demonstrate a defect in OVA-specific IgG2a production after s.c. immunization. The defect in priming of CD18−/− CD4+ T cells persists even in the presence of proliferating CD18+/− CD4+ T cells and in lymphoid structures to which there is no migration defect. Taken together, these results demonstrate that LFA-1 is required for optimal CD4+ T cell priming in vivo.Keywords
This publication has 49 references indexed in Scilit:
- Preferential Accumulation of Antigen-specific Effector CD4 T Cells at an Antigen Injection Site Involves CD62E-dependent Migration but Not Local ProliferationJournal of Experimental Medicine, 2003
- β2 integrins are required for skin homing of primed T cells but not for priming naive T cellsJournal of Clinical Investigation, 2002
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Molecular Mechanisms of Lymphocyte Homing to Peripheral Lymph NodesJournal of Experimental Medicine, 1998
- Requirements for Peptide-induced T Cell Receptor Downregulation on Naive CD8+ T CellsJournal of Experimental Medicine, 1997
- LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor.Journal of Experimental Medicine, 1996
- Ins and outs of LFA-1Immunology Today, 1995
- Prevention of fetal bowel allograft rejection by combined treatment with anti-ICAM-1 and anti-LFA-1 antibodiesJournal of Pediatric Surgery, 1995
- Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.Journal of Experimental Medicine, 1991
- Adhesion receptors of the immune systemNature, 1990